The long road from the first symptoms of mite allergy to mite-specific immunotherapy

[1]  G. Scadding,et al.  Epidemiology of chronic rhinosinusitis: prevalence and risk factors. , 2022, The journal of allergy and clinical immunology. In practice.

[2]  A. Ellis,et al.  Patient and physician perceptions of seasonal allergic rhinitis and allergen immunotherapy: a parallel physician patient survey , 2020, Allergy, Asthma & Clinical Immunology.

[3]  C. Rondón,et al.  Bronchial asthma triggered by house dust mites in patients with local allergic rhinitis , 2019, Allergy.

[4]  R. Mosges,et al.  EAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma , 2019, Allergy.

[5]  W. Randerath,et al.  [Different Prevalences of Pneumological Disease Patterns in Outpatient and Inpatient Care]. , 2019, Pneumologie.

[6]  A. Chaker,et al.  [Costs of allergic diseases and saving potential by allergen-specific immunotherapy : A personal assessment]. , 2017, HNO.

[7]  A. Chaker,et al.  Kosten allergischer Erkrankungen und Einsparpotenziale durch die allergenspezifische Immuntherapie , 2017, HNO.

[8]  L. Klimek,et al.  Früher diagnostizieren, besser therapieren , 2017, Allergo Journal.

[9]  P. Demoly,et al.  Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy , 2017, Expert review of clinical immunology.

[10]  K. Bergmann,et al.  Current status of allergy prevalence in Germany , 2016, Allergo Journal International.

[11]  L. Klimek,et al.  Allergic disorders of the respiratory tract — findings from a large patient sample in the German statutory health insurance system , 2013, Allergo Journal.

[12]  D. Ryan,et al.  Allergy management in primary care across European countries – actual status , 2013, Allergy.

[13]  S. Mcguirk,et al.  Abstracts , 1984, Journal of Vascular Research.

[14]  C. Saçkesen,et al.  Burden of rhinitis in children with asthma , 2005 .